Edoardo Poletto

It was an honour and a pleasure for us to host Professor Manuel Maglione from Innsbruck! A valuable opportunity to share knowledge and "tips and tricks" in HPB, robotic and minimally invasive surgery, and a multidisciplinary approach to liver diseases. Thanks, Manuel! Tschuss!

@magpao @UNIMORE_univ @TorzilliGuido @HumanitasMilano Fabrizio Di Benedetto, Fabio Procopio, @ARuzzenente @UniVerona @conci_simone @LauraAlaimo5 #HPBSurgery #RoboticSurgery

@AnnSurgOncol @BasGrootKoerkam @PB_Olthof @BotelhoDra @SyedAAhmad5 @HPBVerona

Featured: Operative and Oncological Outcomes of #VascularResection and Reconstruction for #PerihilarCholangiocarcinoma . @edoardo_poletto @BasGrootKoerkam @PB_Olthof ow.ly/xpE150XhNiV @BotelhoDra @SyedAAhmad5

Laparoscopic Sg8 Segmentectomy with cranio-caudal approach: is it the “new” standard tecniques or just a passing trend?

Our Chief of Surgery, prof Andrea Ruzzenente, talking about augmented reality 🖥️ and 3️⃣D reconstruction in MILS at the IgoMILS school: 🩻 Understanding the anatomy 🗺️ Surgical Planning and Navigation 📚 Teaching And many more advantages!

How to predict the risk of early recurrence in peri-hilar cholangiocarcinoma? Try the Preoperative Recurrence Score!!!🕵️ 4 easy-to-asses features: 1️⃣ size >18mm 2️⃣ suspected LN 3️⃣ HA involvement 4️⃣ PV involvement 🇮🇹 Cohort & 2 🇳🇱🇻🇦Validation Cohorts 👉 authors.elsevier.com/a/1jvwj2gGSo76…

🚨 Ultimi posti disponibili per il 4° corso teorico-pratico di chirurgia colo-rettale robot-assistita 🤖 . Il corso prevede training di simulazione, pratica su modello animale e live surgery con una faculty di eccezione 👨‍⚕️ !

It's a wrap for the 4th edition of our hands-on course on Robotic HPB surgery. 🧑‍⚕️A faculty with experts from 3 highly experienced centers. 🎮Hands-on practice on simulator and animal model. 📽 Live surgery. Tutoring and Mentoring as means to progress with innovation in surgery!

🔎 Check out our last paper on Percutaneous Ablation in Perivascular-HCC 👎 Not for all lesions, only not suitable for 🔪 👌 Less than 2 cm 👍 in proximity to smaller vessels (<5mm) 🤔 Glissoneal better than the Hepatic vein? doi.org/10.1016/j.crad…

🔢How many subtypes of intrahepatic cholangiocarcinoma do you know? 👩‍🔬Multi-omics analyses help answer the question. 🥼What about the clinical characteristics? Check out the Systematic Review from our team at @HPBVerona @ARuzzenente 🔎mdpi.com/2072-6694/16/1…

Is Total Neoadjuvant Therapy better for locally advanced rectal cancer? Check out our new Systematic Review and Meta-Analysis. - 2⃣7⃣ RCTs! - 📈increased complete pathological response! - 👍good tolerability and operative outcomes! A new first-line treatment?

Portal stenting in recurrent or locally advanced pCCA! - Safe & Feasible (💯% success rate!, 13% overall complications) 💪 - Improves QoL 🆙 and allows patients to get Chemo! 💊 Check out our paper on EJSO DOI: 10.1016/j.ejso.2024.107984 @UniVerona #HPB #liversurgery #pcca

RUN FOR SURGERY, RUN FOR LIFE! Today our unit is running the StraVerona, a charity run through the streets of our beautiful city. 🏃🏃‍♀️🏃🏃‍♀️ Watch out for the surgeons on the run!

@UniVerona @HPBVerona @ARuzzenente @BasGrootKoerkam

From 🌫️ foggy Verona to ☀️ sunny Miami, honored to present our multicenter 🏨🏥 work at the Presidential Session of the AHPBA24! 🌎 ✔️Vascular reconstruction for pCCA is feasible even if ⬆️☠️ 🔝OS is comparable to other resected patients!

Check out our new paper on peri-hilar cholangiocarcinoma and the clinical impact of portal stenting, authors.elsevier.com/a/1iZcU2gGSo74… @Aicep4 @UniVerona @IHPBA @ejsotweets

ABC factors validated as prognostic staging for localized PDAC. @MarcBesselink @EileenMOReilly @CDTzeng @Gio_Marchegiani @Aiims1742 @nigeljamieson #PancreaticCancer ascopubs.org/doi/10.1200/JC…

Back from where it all started! I'm thrilled and honored to enter as a surgeon the same rooms i just left as a resident! @UniVerona #hpbsurgery